@article{3095265,
    title = "Mantle-cell lymphoma (multiple lymphomatous polyposis) of the entire GI tract",
    author = "Michopoulos, S. and Petraki, K. and Matsouka, C. and Kastritis, E. and Chrysanthopoulou, H. and Dimopoulos, M.A.",
    journal = "Journal of Clinical Oncology",
    year = "2008",
    volume = "26",
    number = "9",
    pages = "1555-1557",
    issn = "0732-183X, 1527-7755",
    doi = "10.1200/JCO.2007.14.9856",
    keywords = "bortezomib;  cyclophosphamide;  doxorubicin;  prednisone;  rituximab;  vincristine;  antineoplastic agent;  boronic acid derivative;  bortezomib;  cyclophosphamide;  doxorubicin;  monoclonal antibody;  prednisone;  pyrazine derivative;  rituximab;  vincristine, aged;  article;  bone marrow biopsy;  case report;  colonoscopy;  disease severity;  gastrointestinal biopsy;  gastrointestinal endoscopy;  gastrointestinal polyposis;  human;  human tissue;  intestine ulcer;  male;  mantle cell lymphoma;  multiple cycle treatment;  priority journal;  prognosis;  symptomatology;  treatment response;  unspecified side effect;  drug administration;  gastrointestinal hemorrhage;  gastrointestinal tumor;  hospitalization;  immunohistochemistry;  mantle cell lymphoma;  pathology;  treatment outcome, Aged;  Antibodies, Monoclonal;  Antineoplastic Combined Chemotherapy Protocols;  Boronic Acids;  Cyclophosphamide;  Doxorubicin;  Drug Administration Schedule;  Gastrointestinal Hemorrhage;  Gastrointestinal Neoplasms;  Humans;  Immunohistochemistry;  Lymphoma, Mantle-Cell;  Male;  Prednisone;  Prognosis;  Pyrazines;  Severity of Illness Index;  Treatment Outcome;  Vincristine"
}